Aon Makes Strategic Investment in eMed to Enhance Obesity Solutions with GLP-1 Platform

Aon Expands Obesity Solutions Through Strategic Investment in eMed

Aon plc, a renowned global professional services firm, has recently announced a significant strategic investment in eMed Population Health, Inc., a pioneering company that specializes in the delivery of GLP-1 programs. This move is designed to enhance employer access to GLP-1 therapies while expanding the solutions available for obesity management. This collaboration comes on the heels of Aon's successful launch earlier this year of its subsidized GLP-1 weight management benefit program tailored for its U.S. workforce, created in partnership with eMed.

The results from Aon's GLP-1 program have been impressive. Within just six months of its launch, over 1,200 employees registered for the program, achieving an average weight loss of 22.4 pounds, along with a remarkable 95 percent retention rate. This indicates not only the program's effectiveness but also a keen interest among employees in utilizing these transformational weight loss solutions. Aon's investment aims to build on this success and enable eMed to broaden the distribution of its healthcare platform, which effectively combines at-home diagnostics, proctor-led screenings, clinician-guided prescribing, and ongoing adherence support, ultimately benefiting a larger number of employers and patients.

Lisa Stevens, Aon’s Chief Administrative Officer, stressed the vital significance of integrating GLP-1 medication coverage into the firm's Total Rewards strategy, emphasizing how these decisions can profoundly impact the present and future health of the workforce. "When you witness the benefits it provides to colleagues, it reiterates how the choices employers make today influence the health and effectiveness of their teams and organizations in the long run," Stevens explained.

Furthermore, she added that this strategic investment in eMed positions Aon to offer a comprehensive global solution centered on medication adherence. This approach is essential for helping employers tackle long-term health costs while simultaneously enhancing their employees’ quality of life. The collaboration is seen as a major milestone for eMed in achieving its goal to deliver sustainable healthcare solutions through a data-driven and integrated experience.

CEO of eMed, Linda Yaccarino, expressed her enthusiasm about the partnership, stating, "Today symbolizes a transformative alliance between Aon and eMed, marking a win for both payers and participants. The investment from Aon validates and accelerates our shared vision for market transformation. We will now have the means to enhance our solutions focusing on medication adherence—crucial for helping employers reduce long-term health costs while improving the overall quality of life of their employees."

Aon recognizes the rising critique concerning the growing costs associated with GLP-1 medications, prompting strategic deliberations from many employers striving to address obesity and related chronic conditions. Farheen Dam, Aon's Head of Health for North America, highlighted the belief that a one-size-fits-all strategy will not suffice for managing obesity via GLP-1s effectively. Instead, Aon’s approach relies on thorough data analysis and strategic guidance to help employers develop tailored GLP-1 strategies aligned with their unique employee populations and objectives.

As part of its ongoing commitment to enhancing health outcomes via GLP-1 solutions, Aon continues to build a comprehensive suite of offerings supported by industry-leading expertise and advisory capabilities. Earlier this year, Aon shared critical insights from its multi-year analysis of U.S. health claims data, which underscored the potential benefits of GLP-1 medications in effectively managing obesity and improving overall health results.

The collaboration between Aon and eMed points toward a future where innovative healthcare solutions are tailored to the needs of the workforce while also serving as a valuable resource for employers seeking to improve employee wellbeing. Through this partnership, both companies envision a healthcare ecosystem where access to effective weight management solutions is more widespread, ultimately driving positive transformations in population health.